AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-98
Results: 1-25/98

Authors: LECLEACH L ROUJEAU JC
Citation: L. Lecleach et Jc. Roujeau, TOXIC EPIDERMAL NECROLYSIS, Journal of dermatological treatment, 9(1), 1998, pp. 35-37

Authors: WOLKENSTEIN PE ROUJEAU JC REVUZ J
Citation: Pe. Wolkenstein et al., DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS, Clinics in dermatology, 16(3), 1998, pp. 399-408

Authors: LECLEACH L BOCQUET H ROUJEAU JC
Citation: L. Lecleach et al., REACTIONS AND INTERACTIONS OF SOME COMMONLY USED SYSTEMIC DRUGS IN DERMATOLOGY, Dermatologic clinics, 16(2), 1998, pp. 421

Authors: JOLY P TANASESCU S WOLKENSTEIN P BOCQUET H GILBERT D THOMINE E WECHSLER J ROUJEAU JC REVUZ J TRON E LAURET P
Citation: P. Joly et al., LICHENOID ERYTHRODERMIC BULLOUS PEMPHIGOID OF THE AFRICAN PATIENT, Journal of the American Academy of Dermatology, 39(5), 1998, pp. 691-697

Authors: KOSSEIANBAL I BOCQUET H BENETON N ENCAOUA R DEFORGES L ROUJEAU JC REVUZ J
Citation: I. Kosseianbal et al., HYPERSENSIBILITY SYNDROME IN A PATIENT WI TH MYCOPLASMA-PNEUMONIAE INFECTION, Annales de dermatologie et de venereologie, 125(5), 1998, pp. 328-330

Authors: ROUJEAU JC
Citation: Jc. Roujeau, HOW SHOULD DRUG RISK BE ASSESSED, Annales de dermatologie et de venereologie, 125(10), 1998, pp. 673-675

Authors: WOLKENSTEIN P LATARJET J ROUJEAU JC DUGUET C BOUDEAU S VAILLANT L MAIGNAN M SCHUHMACHER MH MILPIED B PILORGET A BOCQUET H BRUNBUISSON C REVUZ J
Citation: P. Wolkenstein et al., RANDOMIZED COMPARISON OF THALIDOMIDE VERSUS PLACEBO IN TOXIC EPIDERMAL NECROLYSIS, Lancet, 352(9140), 1998, pp. 1586-1589

Authors: MENEUX E WOLKENSTEIN P HADDAD B ROUJEAU JC REVUZ J PANIEL BJ
Citation: E. Meneux et al., VULVO-VAGINAL INVOLVEMENT IN TOXIC EPIDERMAL NECROLYSIS - A RETROSPECTIVE STUDY OF 40 CASES, Obstetrics and gynecology, 91(2), 1998, pp. 283-287

Authors: WOLKENSTEIN P LATARGET J ROUJEAU JC DUGUET C BOUDEAU S VAILLANT L MAIGNAN M MILPIED B BOCQUET H REVUZ J
Citation: P. Wolkenstein et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF THALIDOMIDE VERSUS PLACEBO IN TOXIC EPIDERMAL NECROLYSIS - OVERMORTALITY IN TREATED GROUP, Journal of investigative dermatology, 110(4), 1998, pp. 516-516

Authors: BASTUJIGARIN S TURKI H MOKHTAR I NOUIRA R FAZAA B JOMAA B ZAHAF A BENOSMAN A SOUISSI R REVUZ J ROUJEAU JC KAMOUN MR
Citation: S. Bastujigarin et al., RISK-FACTORS OF TUNISIAN PEMPHIGUS - A CASE-CONTROL STUDY, Journal of investigative dermatology, 110(4), 1998, pp. 590-590

Authors: VAILLANT L BERNARD P JOLY P PROST C LABEILLE B BEDANE C ARBEILLE B THOMINE E BERTRAND P LOK C ROUJEAU JC
Citation: L. Vaillant et al., EVALUATION OF CLINICAL-CRITERIA FOR DIAGNOSIS OF BULLOUS PEMPHIGOID, Archives of dermatology, 134(9), 1998, pp. 1075-1080

Authors: BOCQUET H BAGOT M ROUJEAU JC
Citation: H. Bocquet et al., DIDMOHS - A PROPOSED CONSENSUS NOMENCLATURE FOR THE DRUG-INDUCED DELAYED MULTIORGAN HYPERSENSITIVITY SYNDROME - IN REPLY, Archives of dermatology, 134(7), 1998, pp. 875-876

Authors: MANSOURI S DUBERTRET L BASTUJIGARIN S DOMBRET H ROUJEAU JC ARACTINGI S
Citation: S. Mansouri et al., ROLE OF DRUGS IN CUTANEOUS ERUPTIONS AFTER CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA, Archives of dermatology, 134(7), 1998, pp. 881-882

Authors: ROUJEAU JC LOK C BASTUJIGARIN S MHALLA S ENGINGER V BERNARD P
Citation: Jc. Roujeau et al., HIGH-RISK OF DEATH IN ELDERLY PATIENTS WITH EXTENSIVE BULLOUS PEMPHIGOID, Archives of dermatology, 134(4), 1998, pp. 465-469

Authors: CREMNITER D BAUDIN M ROUJEAU JC PROST C CONSOLI SG FRANCES C CHOSIDOW O
Citation: D. Cremniter et al., STRESSFUL LIFE EVENTS AS POTENTIAL TRIGGERS OF PEMPHIGUS, Archives of dermatology, 134(11), 1998, pp. 1486-1487

Authors: BENCHIKHI H ROUJEAU JC LEVENT M GOUAULTHEILMANN M REVUZ J COSNES A
Citation: H. Benchikhi et al., CHIBLAINS AND RAYNAUD PHENOMENON ARE USUALLY NOT A SIGN OF HEREDITARYPROTEIN-C AND S-DEFICIENCIES, Acta dermato-venereologica, 78(5), 1998, pp. 351-352

Authors: ROUJEAU JC
Citation: Jc. Roujeau, SEVERE DRUG-INDUCED BLISTERING DISORDERS, Revue du rhumatisme, 64(1), 1997, pp. 5-9

Authors: LEBARGY F WOLKENSTEIN P GISSELBRECHT M LANGE F FLEURYFEITH J DELCLAUX C ROUPIE E REVUZ J ROUJEAU JC
Citation: F. Lebargy et al., PULMONARY COMPLICATIONS IN TOXIC EPIDERMAL NECROLYSIS - A PROSPECTIVECLINICAL-STUDY, Intensive care medicine, 23(12), 1997, pp. 1237-1244

Authors: BOCQUET H ROUJEAU JC
Citation: H. Bocquet et Jc. Roujeau, SEVERE DRUG-INDUCED SKIN REACTIONS, Revue francaise d'allergologie et d'immunologie clinique, 37(5), 1997, pp. 651-659

Authors: LECAM MT WOLKENSTEIN P COSNES A BOCQUET H GAULARD P TULLIEZ M CORDONNIER C ROUJEAU JC BAGOT M REVUZ J
Citation: Mt. Lecam et al., ACUTE MAST-CELL LEUKEMIA REVEALED BY FLUSH SYNDROME, Annales de dermatologie et de venereologie, 124(9), 1997, pp. 621-622

Authors: BENETON N BOCQUET H COSNES A REVUZ J ROUJEAU JC
Citation: N. Beneton et al., BENEFIT-RISK ASSESSMENT OF ACNE THERAPIES, Lancet, 349(9060), 1997, pp. 1252-1252

Authors: MENEUX E PANIEL BJ POUGET F REVUZ J ROUJEAU JC WOLKENSTEIN P
Citation: E. Meneux et al., VULVO-VAGINAL SEQUELAE IN TOXIC EPIDERMAL NECROLYSIS, Journal of reproductive medicine, 42(3), 1997, pp. 153-156

Authors: RAUX G GILBERT D JOLY P LAURET P PROST C ROUJEAU JC LEFRANC MP TRON F
Citation: G. Raux et al., DETERMINATION OF SUSCEPTIBILITY FACTORS IN PEMPHIGUS AND BULLOUS PEMPHIGOID - GENETIC-POLYMORPHISM OF IMMUNOGLOBULIN HEAVY AND LIGHT-CHAIN GENES, Journal of investigative dermatology, 109(3), 1997, pp. 418-418

Authors: RAUX G CHRIST M GILBERT D JOLY P LAURET P PROST C ROUJEAU JC LEFRANC MP TRON F
Citation: G. Raux et al., DETERMINATION OF SUSCEPTIBILITY FACTORS IN PEMPHIGUS AND BULLOUS PEMPHIGOID - GENETIC-POLYMORPHISM OF IMMUNOGLOBULIN HEAVY AND LIGHT-CHAIN GENES, Journal of investigative dermatology, 108(5), 1997, pp. 69-69

Authors: DUPUY A BENCHIKHI H BASTUJIGARIN S DANG PM SASSOLAS B CHOSIDOW O VAILLANT L GUILLAUME JC GROB JJ ROUJEAU JC
Citation: A. Dupuy et al., RISK-FACTORS OF LEG ERYSIPELA - A MULTICENTRIC CASE-CONTROL STUDY, Journal of investigative dermatology, 108(3), 1997, pp. 12-12
Risultati: 1-25 | 26-50 | 51-75 | 76-98